全球馬匹保健市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計馬匹保健市場將從 2025 年的 28.7 億美元成長到 2034 年的 54.5 億美元，2026 年至 2034 年的複合年成長率為 7.39%。

隨著馬匹健康和獸醫護理的重要性日益凸顯，全球馬匹醫療保健市場正蓬勃發展。馬匹廣泛應用於運動、賽馬、農業和休閒娛樂活動，因此，馬匹的健康管理成為馬主和馴馬師的首要任務。馬匹獸醫診所的增加以及人們對預防醫學實踐意識提升，正在推動對先進馬匹醫療保健產品和服務的需求。

推動市場發展的關鍵因素包括專為馬匹設計的疫苗、診斷工具、營養補充劑和藥物日益普及的現象。獸醫專業人員正致力於預防保健和疾病早期檢測，以維持馬匹的健康與表現。此外，獸醫診斷技術和治療方法的進步也提升了馬匹醫療保健服務的整體品質。

未來幾年，受全球馬術運動和休閒活動蓬勃發展的推動，全球馬匹醫療保健市場預計將持續成長。獸醫基礎設施和研究投入的增加，正助力開發創新馬匹醫療保健解決方案。隨著馬主日益重視馬匹的健康和福利，對專業馬匹醫療保健服務的需求也將隨之成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球馬匹保健市場：依產品分類

• 市場分析、洞察與預測
• 藥物分類（抗感染劑、抗發炎藥、驅蟲藥、其他）
• 疫苗（去活化疫苗、減毒活病毒疫苗、重組疫苗等）
• 飼料添加劑

第5章 全球馬匹保健市場：依疾病類型分類

• 市場分析、洞察與預測
• 西尼羅病毒
• 馬狂犬病
• 馬流感
• 馬皰疹病毒
• 波托馬克河馬熱
• 破傷風
• 其他

第6章：全球馬匹保健市場：依通路分類

• 市場分析、洞察與預測
• 獸醫醫院和診所
• 零售藥局和藥房
• 其他

第7章 全球馬匹保健市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis Inc
  • Ceva SantAfA（C）Animale
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Vetoquinol
  • Neogen Corporation
  • Virbac
  • Merck & Co. Inc
  • Norbrook Laboratories Ltd
  • Purina Animal Nutrition LLC
  • Kyoritsuseiyaku Corporation
  • Equine Products UK Ltd

The Equine Healthcare Market size is expected to reach USD 5.45 Billion in 2034 from USD 2.87 Billion (2025) growing at a CAGR of 7.39% during 2026-2034.

The Global Equine Healthcare Market is gaining momentum as the importance of horse health and veterinary care continues to increase. Horses are widely used in sports, racing, agriculture, and recreational activities, making their health management a priority for owners and trainers. The rising number of equine veterinary clinics and improved awareness of preventive healthcare practices are driving the demand for advanced equine healthcare products and services.

Key market drivers include the increasing adoption of vaccines, diagnostic tools, nutritional supplements, and pharmaceutical treatments designed specifically for horses. Veterinary professionals are focusing on preventive care and early disease detection to maintain the performance and well-being of horses. Additionally, technological advancements in veterinary diagnostics and treatment methods are improving the overall quality of equine healthcare services.

In the coming years, the Global Equine Healthcare Market is expected to expand as equine sports and recreational activities continue to grow worldwide. Increased investment in veterinary infrastructure and research is supporting the development of innovative healthcare solutions for horses. As horse owners increasingly prioritize animal health and welfare, the demand for specialized equine healthcare services is likely to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others)
• Vaccines (Inactivated, Live Attenuated, Recombinant, Others)
• Supplemental Feed Additives

By Disease Type

• West Nile Virus
• Equine Rabies
• Equine Influenza
• Equine Herpes Virus
• Potomac Horse Fever
• Tetanus
• Others

By Distribution Channel

• Veterinary Hospitals And Clinics
• Retail Pharmacies And Drug Stores
• Others

COMPANIES PROFILED

• Zoetis Inc, Ceva Sant Animale, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Vetoquinol, Neogen Corporation, Virbac, Merck Co Inc, Norbrook Laboratories Ltd, Purina Animal Nutrition LLC, Kyoritsuseiyaku Corporation, Equine Products UK Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EQUINE HEALTHCARE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines (Inactivated, Live Attenuated, Recombinant, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Supplemental Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EQUINE HEALTHCARE MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. West Nile Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Equine Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Equine Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Equine Herpes Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Potomac Horse Fever Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tetanus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EQUINE HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies And Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EQUINE HEALTHCARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Disease Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Disease Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Disease Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Disease Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Disease Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EQUINE HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zoetis Inc
  • 9.2.2 Ceva SantAfA(C) Animale
  • 9.2.3 Elanco Animal Health Incorporated
  • 9.2.4 Boehringer Ingelheim International GmbH
  • 9.2.5 Vetoquinol
  • 9.2.6 Neogen Corporation
  • 9.2.7 Virbac
  • 9.2.8 Merck & Co. Inc
  • 9.2.9 Norbrook Laboratories Ltd
  • 9.2.10 Purina Animal Nutrition LLC
  • 9.2.11 Kyoritsuseiyaku Corporation
  • 9.2.12 Equine Products UK Ltd